Short-term effects of a standardized beverage from aqueous extracts of Hibiscus sabdariffa and Stevia rebaudiana on diastolic function of Cameroonians with type 2 diabetes - 25/12/18
pages | 2 |
Iconographies | 0 |
Vidéos | 0 |
Autres | 0 |
Résumé |
Background |
Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic populations. Safe beverages of medicinal plants contribute as a strategy for the prevention and management of these complications. We investigated the effects of a drink mixture of Hibiscus sabdariffa and Stevia rebaudiana extracts on diastolic function in a group of type 2 diabetes patients.
Methods |
We carried out a non-randomized open-label, one-arm clinical trial. Patients with type 2 diabetes and glycated hemoglobin<8% were included. Each participant consumed 425mL of a standardized drink every morning after breakfast over a period of 8 weeks. The effects on the E/A ratio (Mitral peak velocity of early filling E/Mitral peak velocity of last filling A) and lipid profile were determined.
Results |
We included 20 patients (13 women and 7 men) with a median age of 59 years [56–63.5] and type 2 diabetes of a duration of 8 years [3.25–11.5]. Transthoracic ultrasound at baseline showed 12 patients with diastolic dysfunction. After the 8 weeks intervention, lipid profile parameters improved significantly: triglycerides decreased by 45.58% (P=0.008), LDL-cholesterol by 21% (P=0.018) and HDL-cholesterol increased by 29.26% (P<0.001). Generally, there was an insignificant increase in E/A ratio after intervention, from 0.68 [0.55–1.00] to 0.80 [0.70–0.97], P=0.937. However, patients with diastolic dysfunction at baseline showed a significant increase in the E/A ratio from 0.60 [0.50–0.69] to 0.70 [0.60–0.95] corresponding to a variation of 16.7% (P=0.016). We did not find any significant side effects and the drink was judged to be quite palatable in 18/20 patients.
Conclusion |
A drink associating Hibiscus sabdariffa with Stevia rebaudiana has beneficial effects on the diastolic function of type 2 diabetes patients and also on their lipid profile.
Le texte complet de cet article est disponible en PDF.Plan
Vol 11 - N° 1
P. 154-155 - janvier 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?